Latest News

BSAC Welcomes G20 Leaders’ Declaration on Combating AMR

The British Society for Antimicrobial Chemotherapy (BSAC) has welcomed the publication of the G20 Leaders’ Declaration, which followed high-level meetings… Read more »

‘Antibiotic shortage puts patients at risk, doctors fear’

Philip Howard, Vice President of the British Society for Antimicrobial Chemotherapy (BSAC), has talked to the national press about the… Read more »

The use of topical antibiotics: an invitation to complete a survey by ...

The British Society for Antimicrobial Chemotherapy (BSAC) and European Wound Management Association (EWMA) would like to invite you to participate… Read more »

Ensuring universal access to old antibiotics: a critical but neglected...

Leading international healthcare professionals, including the President and President-elect of BSAC have called for steps to ensure universal and equitable… Read more »

Hand Hygiene Day 2017 is here!

BSAC is calling on all members and stakeholders to support World Health Organisation Hand Hygiene Day by fighting antimicrobial resistance through… Read more »

Antibiotic stewardship around the globe – in top two lectures at...

BSAC is delighted to announce that the lecture given by Dilip Nathwani OBE, President of BSAC was one of the… Read more »

DH advises on Piperacillin-Tazobactam injection supply problems

Following on from our previous communications, we have been continuing to monitor the supply situation for piperacillin/tazobactam (pip/taz) injection.  As… Read more »

BSAC welcomes HEE call for training to combat resistance

BSAC welcome the call by Health Education England (HEE) to employers and healthcare providers to do more to make sure their… Read more »


BSAC is grateful to the following company who provided an unrestricted educational grant to support the cost of developing this course:… Read more »

New resource to support management of UTI in primary care

The education resource to support primary care teams in reducing unnecessary antibiotic use for respiratory infections and the addition of… Read more »

Piperacillin 4g / Tazobactam 500mg powder and solvent for solution for...

Further to previous correspondence regarding pip/taz, DH/CMU continues to engage with all licenced suppliers to ascertain the overall supply position…. Read more »

Young Scientist Seat on Committee for one year

The BSAC susceptibility testing standing committee supports the development and implementation of high-quality antimicrobial susceptibility testing across the UK and… Read more »